Screening compound: C33H39N3O4 (E456-1689)

Screening compound: C<sub>33</sub>H<sub>39</sub>N<sub>3</sub>O<sub>4</sub> (E456-1689)
Screening compound: C<sub>33</sub>H<sub>39</sub>N<sub>3</sub>O<sub>4</sub> (E456-1689) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C33H39N3O4 (E456-1689)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E456-1689

Molecular Formula

C33H39N3O4 (C33 H39 N3 O4)

Compound Name

N-{3-[(2,3-dimethylcyclohexyl)[(furan-2-yl)methyl]amino]propyl}-2-(4-methoxyphenyl)-1-oxo-1,2-dihydroisoquinoline-4-carboxamide

IUPAC name

N-{3-[(23-dimethylcyclohexyl)[(furan-2-yl)methyl]amino]propyl}-2-(4-methoxyphenyl)-1-oxo-12-dihydroisoquinoline-4-carboxamide

SMILES

CC(CCC1)C(C)C1N(CCCNC(C(c1c2cccc1)=CN(c(cc1)ccc1OC)C2=O)=O)Cc1ccco1

InChI

InChI=1S/C33H39N3O4/c1-23-9-6-13-31(24(23)2)35(21-27-10-7-20-40-27)19-8-18-34-32(37)30-22-36(25-14-16-26(39-3)17-15-25)33(38)29-12-5-4-11-28(29)30/h4-5,7,10-12,14-17,20,22-24,31H,6,8-9,13,18-19,21H2,1-3H3,(H,34,37)

InChI Key

HWHJDXUHNMMLSZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14853996

C33H39N3O4 (E456-1689) in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

GPCR Targeted Library (31838 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C33H39N3O4 (E456-1689) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C33H39N3O4 (E456-1689)?
Check Price and Availability of C33H39N3O4 (E456-1689), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C33H39N3O4 (E456-1689) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C33H39N3O4 (E456-1689)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C33H39N3O4 (E456-1689)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C33H39N3O4 (E456-1689) available by request